An investigation on behalf of investors of bluebird bio Inc (NASDAQ:BLUE) shares over potential securities laws violations by bluebird bio and certain of its directors and officers in connection certain financial statements was announced. Cambrudge, MA based bluebird bio, Inc. is a clinical-stage biotechnology company.
Investors who purchased shares of bluebird bio Inc (NASDAQ:BLUE), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm focuses on certain statements by bluebird bio regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
bluebird bio Inc reported that its annual Total Revenue rose from $0.34 million in 2012 to $25.42 million in 2014. Shares of bluebird bio Inc (NASDAQ:BLUE) grew from $17.69 per share in May 2014 to as high as $197.30 per share on May 29, 2015. Since then NASDAQ:BLUE shares declined to as low as $66.51 per share on November 5, 2015.
Those who purchased shares of bluebird bio Inc (NASDAQ:BLUE) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com